These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2424597)

  • 1. Promotion of tumor antigenicity in EL-4 leukemia cells by hydrostatic pressure.
    Richert L; Or A; Shinitzky M
    Cancer Immunol Immunother; 1986; 22(2):119-24. PubMed ID: 2424597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active immunization of hamsters against pancreatic carcinoma with lipid-treated cells or their shed antigens.
    Skornick Y; Kurman CC; Sindelar WF
    Cancer Res; 1984 Mar; 44(3):946-8. PubMed ID: 6692417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of growth and metastases in mice by immunization with cholesterol hemisuccinate-enriched tumor cells.
    Skornick Y; Gorelik E; Klausner J; Shinitzky M; Sindelar WF
    Cancer Lett; 1984 Dec; 25(2):153-61. PubMed ID: 6509434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of protective and cytotoxic immune responses in vivo against metabolically inactivated and untreated cells of a mutagenized tumor line (requirements for tumor immunogenicity).
    Wehrmaker A; Lehmann V; Dröge W
    Cell Immunol; 1986 Sep; 101(2):290-8. PubMed ID: 2428514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased projection of MHC and tumor antigens in murine B16-BL6 melanoma induced by hydrostatic pressure and chemical crosslinking.
    Ramakrishna V; Eisenthal A; Skornick Y; Shinitzky M
    Cancer Immunol Immunother; 1993 May; 36(5):293-9. PubMed ID: 8477415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoprophylaxis and cytotoxic effector cells against EL 4 leukemia induced in syngeneic C57BL/6J mice by use of irradiated EL 4 cells.
    Johnson TS; Hudson JL; Feldman ME; Irvin GL
    J Natl Cancer Inst; 1975 Sep; 55(3):561-7. PubMed ID: 51089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of membrane function by lipids; implications for tumor development.
    Shinitzky M; Skornick Y; Gorelik E; Sindelar W
    Prog Clin Biol Res; 1983; 132B():425-33. PubMed ID: 6634764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topographical distribution and association of tumor--associated antigens and their role in antigenicity in rat tumor cells.
    Moriuchi T
    Hokkaido Igaku Zasshi; 1979 Sep; 54(5):487-99. PubMed ID: 93561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomes as a tool to study the role of membrane presentation in the immunogenicity of a MuLV-related tumor antigen.
    Gerlier D; Bakouche O; Dore JF
    J Immunol; 1983 Jul; 131(1):485-90. PubMed ID: 6190925
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-mediated changes of tumour cell immunogenicity and antigenicity.
    Puccetti P; Romani L; Taramelli D; Bonmassar E; Fioretti MC
    Int J Tissue React; 1982; 4(3):189-99. PubMed ID: 6183194
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen.
    Badger CC; Bernstein ID
    J Exp Med; 1983 Mar; 157(3):828-42. PubMed ID: 6403649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiments evaluating antitumor immunity induced by cholesterol hemisuccinate-treated syngeneic cell vaccines.
    Rong GH; Sindelar WF
    J Surg Oncol; 1986 Nov; 33(3):145-50. PubMed ID: 3773533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface antigen expression on chemically induced murine leukaemias.
    Birch JM; Moore M; Craig AW
    Br J Cancer; 1975 Jun; 31(6):630-40. PubMed ID: 1174442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Rauscher-MuLV-induced leukemia, RBL-5, bears two tumor-associated transplantation antigens expressed on distinct molecules.
    Galetto G; Law LW; Rogers MJ
    Int J Cancer; 1985 Dec; 36(6):713-9. PubMed ID: 2415471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
    LaTemple DC; Abrams JT; Zhang SY; Galili U
    Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in cell-surface expression of MHC and Thy-1.2 determinants following treatment with lipid modulating agents.
    Muller CP; Stephany DA; Shinitzky M; Wunderlich JR
    J Immunol; 1983 Sep; 131(3):1356-62. PubMed ID: 6136545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of suppressor T cells in BCNU-mediated rejection of a syngeneic tumor.
    Nagarkatti M; Kaplan AM
    J Immunol; 1985 Aug; 135(2):1510-7. PubMed ID: 3159794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of delayed-type hypersensitivity response to syngeneic tumors in mice prevaccinated with cells modified by hydrostatic pressure and crosslinking.
    Ramakrishna V; Shinitzky M
    Cancer Immunol Immunother; 1991; 33(1):1-8. PubMed ID: 2021954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective tumor immunization induced by cells of elevated membrane-lipid microviscosity.
    Shinitzky M; Skornick Y; Haran-Ghera N
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5313-6. PubMed ID: 116228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.